Oversea-Chinese Banking Corp (OCBC)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
EHC
SRIM
N
MG
Oversea-Chinese Banking Corp (OCBC)'s NVO Position: Q2 2026 in Review
Oversea-Chinese Banking Corp (OCBC) increased its Novo Nordisk (NVO) stake by 13% in Q2 2026, buying an estimated $231K and bringing the position to 45,483 shares worth $2.19M. The position accounts for 0.05% of the portfolio, ranked #193.
Oversea-Chinese Banking Corp (OCBC) first reported a position in NVO in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.06M in Q4 2025. 960 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Oversea-Chinese Banking Corp (OCBC) held 45,483 shares of Novo Nordisk worth $2.19M as of Q2 2026.
- Oversea-Chinese Banking Corp (OCBC) bought 5,386 Novo Nordisk shares in Q2 2026, an estimated $231K.
- Novo Nordisk made up 0.05% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q2 2026, its #193 holding.
- Oversea-Chinese Banking Corp (OCBC) first reported a position in Novo Nordisk in Q1 2024 and has held it in 10 quarters since.
- Oversea-Chinese Banking Corp (OCBC)'s Novo Nordisk position peaked at $3.06M in Q4 2025.
- 960 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q2 2026, filed 11 Aug 2026.